Sectors

Novartis Venture Fund has helped seed a T-cell drug developer founded from Seattle Children's Hospital, Benaroya Research Institute and MIGAL Galilee.

Lepu Medical's immuno-oncology spinoff secured $186m in a round co-led by Ping An Capital and the Sunshine Insurance-backed Riverhead Capital.

American Electric Power and Chevron Technology Ventures were among the existing investors that helped the EV charging service boost its overall funding to $667m.

Access Industries was among the returning investors in a $75m round that brought marketing platform Yotpo’s overall funding to $176m.

M12 and Applied Ventures co-led a $35m round for Syntiant, which is working on chips for artificial intelligence-powered voice processing at the edge.

The T-cell drug developer has launched with $20m from a seed round co-led by corporate venturing unit Novartis Venture Fund.

NetScientific is poised to acquire EMV Capital in an all-share deal after appointing the latter's managing director as its chief executive in May.

Sinpoharm-backed joint venture Sinopharm-CICC was among the investors in a $43.2m round that boosted the antimicrobial drug developer's total funding to near $150m.

Norinchukin Bank has led the cloud-based key system startup’s latest round, which included Globis Capital Partners, Line Ventures, 31Ventures, BSP, NTT Docomo Ventures and Joyo Industrial Research.

Fujita, Industrial Growth Platform and SBI were among the investors in the automation technology developer, a graduate of Nvidia’s Inception Program.

After six years Intel Capital president Wendell Brooks has announced his resignation, with Anthony Lin to take the reins on a temporary basis.